Activation of peroxisome proliferator activator receptor delta in mouse impacts lipid composition and placental development at early stage of gestation

Biology of Reproduction

Volumn 91, Issue 3, 2014, Pages

  Ding, Hongjuan ^a   Zhang, Yiyu ^b   Liu, Lun ^c   Yuan, Hongyan ^a   Qu, Jian ^a   Shen, Rong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Chinese Agricultural Machinery Institute   (China)

Author keywords

Metabolism; Peroxisome proliferator activator receptor delta; Placenta; Ppard; Pregnancy; Signaling pathway; UPLC ESITOFMS approach

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; 5 METHYLTETRAHYDROFOLIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; ARACHIDONIC ACID; CHOLESTEROL SULFATE; DEOXYCORTICOSTERONE ACETATE; DOCOSAPENTAENOIC ACID; ELAIDIC ACID; FATTY ACID; METHANDRIOL; MITOGEN ACTIVATED PROTEIN KINASE; MYRISTIC ACID; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROTEIN; PROTEIN KINASE B; STEARIC ACID; STEROL; SYNCYTIN A; SYNCYTIN B; TRIAMCINOLONE HEXACETONIDE; UNCLASSIFIED DRUG; VACCENIC ACID; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; AKT1 PROTEIN, MOUSE; CELL RECEPTOR; CELL SURFACE RECEPTOR; PATCHED RECEPTORS; PLACENTA PROTEIN; PPARD PROTEIN, MOUSE; SYNCYTIN-A PROTEIN, MOUSE; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CARBOHYDRATE METABOLISM; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOTROPHOBLAST; ELECTROSPRAY; EMBRYO DEVELOPMENT; ENERGY YIELD; ENZYME ACTIVATION; FEMALE; FUSION GENE; GESTATIONAL AGE; GLYCOLYSIS; IMMUNOBLOTTING; LIPID COMPOSITION; LIPID METABOLISM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PLACENTA DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; TROPHOBLAST; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; AGONISTS; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METABOLOME; PLACENTA; RANDOMIZATION; REPRODUCTION; TRANSGENIC MOUSE;

MUS;

ANIMALS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOLYSIS; LIPID METABOLISM; MAP KINASE SIGNALING SYSTEM; METABOLOME; MICE, TRANSGENIC; PHOSPHATIDYLETHANOLAMINES; PLACENTA; PLACENTATION; PREGNANCY; PREGNANCY PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RANDOM ALLOCATION; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES;

EID: 84929503128     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.113.116772     Document Type: Article

References (60)

1. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2001; 2:538-548.
2. Leiser R, Kaufmann P. Placental structure: in a comparative aspect. Exp Clin Endocrinol 1994; 102:122-134.
3. Morrish DW, Dakour J, Li H. Functional regulation of human trophoblast differentiation. J Reprod Immunol 1998; 39:179-195.
4. Cross JC. Placental function in development and disease. Reprod Fertil Dev 2006; 18:71-76.
5. Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol 2009; 7:8.
6. Coleman RA, Haynes EB. Synthesis is and release of fatty acids by human trophoblast cells in culture. J Lipid Res 1987; 28:1335-1341.
7. Peng L, Payne AH. AP-2gamma and the homeodomain protein distal-less 3 are required for placental-specific expression of the murine 3beta-hydroxysteroid dehydrogenase VI gene, Hsd3b6. J Biol Chem 2002; 277:7945-7954.
8. Shalom-Barak T, Zhang X, Chu T, Timothy Schaiff W, Reddy JK, Xu J, Sadovsky Y, Barak Y. Placental PPARc regulates spatiotemporally diverse genes and a unique metabolic network. Dev Biol 2012; 372:143-155.
9. Martínez N, Capobianco E, White V, Pustovrh MC, Higa R, Jawerbaum A. Peroxisome proliferator-activated receptor alpha activation regulates lipid metabolism in the feto-placental unit from diabetic rats. Reproduction 2008; 136:95-103.
10. Barak Y, Sadovsky Y, Shalom-Barak T. PPAR signaling in placental development and function. PPAR Res 2008; 142082.
11. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG, Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997; 11:779-791.
12. Naruhn S, Meissner W, Adhikary T, Kaddatz K, Klein T, Watzer B, Müller-Brüsselbach S, Müller R. 15-Hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist. Mol Pharmacol 2010; 77:171-184.
13. Sznaidman ML, Haffner CD, Maloney PR, Fivush A, Chao E, Goreham D, Sierra ML, LeGrumelec C, Xu HE, Montana VG, Lambert MH, Willson TM, et al. Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)-synthesis and biological activity. Bioorg Med Chem Lett 2003; 13:1517-1521.
14. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2004; 2:e294.
15. Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, Chang S, Lau P, Fowler AJ, Chuang G, Moser AH, Brown BE, Mao-Qiang M, et al. Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 2004; 122:971-983.
16. Vrins CL, van der Velde AE, van den Oever K, Levels JH, Huet S, Oude Elferink RP, Kuipers F, Groen AK. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux. J Lipid Res 2009; 50:2046-2054.
17. Bastie C, Holst D, Gaillard D, Jehl-Pietri C, Grimaldi PA. Expression of peroxisome proliferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts. J Biol Chem 1999; 274:21920-21925.
18. Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Hatae T, Tanabe T, Warner TD, Bishop-Bailey D. Activation of Ppard induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 2007; 27:63-69.
19. Piqueras L, Sanz MJ, Perretti M, Morcillo E, Norling L, Mitchell JA, Li Y, Bishop-Bailey D. Activation of PPARbeta/delta inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release. J Leukoc Biol 2009; 86:115-122.
20. Coll T, Rodrïguez-Calvo R, Barroso E, Serrano L, Eyre E, Palomer X, Vázquez-Carrera M. Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome. Curr Mol Pharmacol 2009; 2:46-55.
21. Michalik L, Desvergne B, Dreyer C, Gavillet M, Laurini RN, Wahli W. PPAR expression and function during vertebrate development. Int J Dev Biol 2002; 46:105-114.
22. Wang Q, Fujii H, Knipp GT. Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 2002; 23:661-671.
23. Wang H, Xie H, Sun X, Tranguch S, Zhang H, Jia X, Wang D, Das SK, Desvergne B, Wahli W, DuBois RN, Dey SK. Stage-specific integration of maternal and embryonic peroxisome proliferator-activated receptor delta signaling is critical to pregnancy success. J Biol Chem 2007; 282:37770-37782.
24. Kang HJ, Hwang SJ, Yoon JA, Jun JH, Lim HJ, Yoon TK, Song H. Activation of peroxisome proliferators-activated receptor delta (PPARdelta) promotes blastocyst hatching in mice. Mol Hum Reprod 2010; 17:653-660.
25. Barak Y, Liao D, He W, Ong ES, Nelson MC, Olefsky JM, Boland R, Evans RM. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A 2002; 99:303-308.
26. Nadra K, Anghel SI, Joye E, Tan NS, Basu-Modak S, Trono D, Wahli W, Desvergne B. Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta. Mol Cell Biol 2006; 26:3266-3281.
27. Kurtz M, Capobianco E, Martínez N, Fernández J, Higa R, White V, Jawerbaum A. Carbaprostacyclin, a PPARdelta agonist, ameliorates excess lipid accumulation in diabetic rat placentas. Life Sci 2010; 86:781-790.
28. Capobianco E, Martínez N, Fornes D, Higa R, Di Marco I, Basualdo MN, Faingold MC, Jawerbaum A. PPAR activation as a regulator of lipid metabolism, nitric oxide production and lipid peroxidation in the placenta from type 2 diabetic patients. Mol Cell Endocrinol 2013; 377:7-15.
29. Tautenhahn R, Patti GJ, Rinehart D, Siuzdak G. XCMS Online: a webbased platform to process untargeted metabolomic data. Anal Chem 2012; 84:5035-5039.
30. Patti GJ, Tautenhahn R, Siuzdak G. Meta-analysis of untargeted metabolomic data from multiple profiling experiments. Nat Protoc 2012; 7:508-516.
31. Zhou B, Wang J, Ressom HW. MetaboSearch: tool for mass-based metabolite identification using multiple databases. PLoS ONE 2012; 7: e40096.
32. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, Fung C, Nikolai L, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007; 35:D521-D526.
33. Tautenhahn R, Cho K, Uritboonthai W, Zhu Z, Patti GJ, Siuzdak G. An accelerated workflow for untargeted metabolomics using the METLIN database. Nat Biotechnol 2012; 30:826-828.
34. Krueger R, Le Buanec B. Action needed to harmonize regulation of low-level presence of biotech traits. Nat Biotechnol 2008; 26:161-162.
35. Park JY, Park BK, Ko JS, Bang S, Song SY, Chung JB. Bile acid analysis in biliary tract cancer. Yonsei Med J 2006; 47:817-825.
36. Larqué E, Ruiz-Palacios M, Koletzko B. Placental regulation of fetal nutrient supply. Curr Opin Clin Nutr Metab Care 2013; 16:292-297.
37. Wang WS, Liu C, Li WJ, Zhu P, Li JN, Sun K. Involvement of CRH and hCG in the induction of aromatase by cortisol in human placental syncytiotrophoblasts. Placenta 2014; 35:30-36.
38. Nishimura K, Nakano N, Chowdhury VS, Kaneto M, Torii M, Hattori MA, Yamauchi N, Kawai M. Effect of PPARb/d agonist on the placentation and embryo-fetal development in rats. Birth Defects Res B Dev Reprod Toxicol 2013; 98:164-169.
39. Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 2001; 98:5306-5311.
40. Ramakrishnan U, Stein AD, Parra-Cabrera S, Wang M, Imhoff-Kunsch B, Juarez-Marquez S, Rivera J, Martorell R. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull 2010; 31:S108-S116.
41. Larqué E, Krauss-Etschmann S, Campoy C, Hartl D, Linde J, Klingler M, Demmelmair H, Caño A, Gil A, Bondy B, Koletzko B. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am J Clin Nutr 2006; 84:853-861.
42. Olsen SF, Østerdal ML, Salvig JD, Weber T, Tabor A, Secher NJ. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomized clinical trial with fish oil. Eur J Clin Nutr 2007; 61:976-985.
43. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 2003; 17:2477-2493.
44. Roberts LD, Murray AJ, Menassa D, Ashmore T, Nicholls AW, Griffin JL. The contrasting roles of PPARdelta and PPARgamma in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue. Genome Biol 2011; 12:R75.
45. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, Watanabe Y, Uchiyama Y, et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 2003; 100:15924-15929.
46. Schuler M, Ali F, Chambon C, Duteil D, Bornert JM, Tardivel A, Desvergne B, Wahli W, Chambon P, Metzger D. PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 2006; 4:407-414.
47. Burton GJ, Fowden AL. The placenta and developmental programming: balancing fetal nutrient demands with maternal resource allocation. Placenta 2012; 33:S23-S27.
48. Maslar IA, Hess DL, Buckmaster JG, Lazur JJ, Stanczyk FZ, Novy MJ. Steroid production by early pregnancy human placental villi in culture. Placenta 1990; 11:277-288.
49. Didolkar AK, Sundaram K. Arachidonic acid is involved in the regulation of hCG induced steroidogenesis in rat Leydig cells. Life Sci 1987; 41:471-477.
50. Romanelli F, Valenca M, Conte D, Isidori A, Negro-Vilar A. Arachidonic acid and its metabolites effects on testosterone production by rat Leydig cells. J Endocrinol Invest 1995; 18:186-193.
51. Shibata E, Kanno T, Tsuchiya A, Kuribayashi K, Tabata C, Nakano T, Nishizaki T. Free fatty acids inhibit protein tyrosine phosphatase 1B and activate Akt. Cell Physiol Biochem 2013; 32:871-879.
52. Nikolakopoulou Z, Nteliopoulos G, Michael-Titus AT, Parkinson EK. Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2. Carcinogenesis 2013; 34:2716-2725.
53. Wu MY, Yang RS, Lin TH, Tang CH, Chiu YC, Liou HC, Fu WM. Enhancement of PLGF production by 15-(S)-HETE via PI3K-Akt, NF-κB and COX-2 pathways in rheumatoid arthritis synovial fibroblast. Eur J Pharmacol 2013; 714:388-396.
54. Tian XY, Wong WT, Wang N, Lu Y, Cheang WS, Liu J, Liu L, Liu Y, Lee SS, Chen ZY, Cooke JP, Yao X, et al. PPARd activation protects endothelial function in diabetic mice. Diabetes 2012; 61:3285-3293.
55. Han JK, Lee HS, Yang HM, Hur J, Jun SI, Kim JY, Cho CH, Koh GY, Peters JM, Park KW, Cho HJ, Lee HY, et al. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Circulation 2008; 118:1021-1033.
56. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003; 113:159-170.
57. Henke C, Ruebner M, Faschingbauer F, Stolt CC, Schaefer N, Lang N, Beckmann MW, Strissel PL, Strick R. Regulation of murine placentogenesis by the retroviral genes Syncytin-A, Syncytin-B and Peg10. Differentiation 2013; 85:150-160.
58. Ruebner M, Langbein M, Strissel PL, Henke C, Schmidt D, Goecke TW, Faschingbauer F, Schild RL, Beckmann MW, Strick R. Regulation of the human endogenous retroviral syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARc/RXRa in placentogenesis. J Cell Biochem 2012; 113:2383-2389.
59. Levytska K, Drewlo S, Baczyk D, Kingdom J. PPAR-γ regulates trophoblast differentiation in the BeWo cell model. PPAR Res 2014; 2014:637251.
60. Bax BE, Bloxam DL. Energy metabolism and glycolysis in human placental trophoblast cells during differentiation. Biochim Biophys Acta 1997; 1319:283-292.